Philips has delivered four consecutive earnings beats with an average surprise of 39.4% and free cash flow at 157% of net income, but trades below its 200-day moving average with declining revenues of -5% and a below-average quality score of 4.7.
Thesis pillars
- Earnings Beat Streak Strength↓Deteriorating
- Revenue Decline Quality Gap→Stable
- Free Cashflow Conversion→Stable
- +1 more pillar — see the Why tab for full reasoning
Koninklijke Philips N.V. NY Reg (PHG) Stock Analysis
Healthcare · Medical Devices
Wait for pullback to $26.04. Weak momentum — blocks BUY_NOW at $26.17. Engine's entry $26.04 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes... Read more
Wait for pullback to $26.04. Weak momentum — blocks BUY_NOW at $26.17. Engine's entry $26.04 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 3 days. Wait until post-earnings. Score 5.5/10, moderate confidence.
Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and earnings proximity 3d<=7d. Suitability: moderate.
Recent developments
updated 2026-07-26Recent Developments — Koninklijke Philips N.V. NY Reg
Latest news
- NEWS Koninklijke Philips NV (PHG) Shares Fall 5.7% -- GF Value Says S - GuruFocus — GuruFocus negative
- NEWS Koninklijke Philips (PHG) Expected to Announce Earnings on Tuesday - MarketBeat — MarketBeat neutral
- NEWS Philips (PHG) Secures FDA Clearance for New SpO2 Clip Sensor - GuruFocus — GuruFocus positive
- NEWS Philips (PHG) Achieves FDA Clearance for Advanced Spectral CT Sy - GuruFocus — GuruFocus positive
- NEWS ETFs Investing in Koninklijke Philips N.V. Sponsored ADR Stocks - TradingView — TradingView neutral
Generated 2026-07-26T09:23:01Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait for pullback to $26.04. Weak momentum — blocks BUY_NOW at $26.17. Engine's entry $26.04 (support + ATR) is the shallowest technical level that clears the 2:1 A.R:R minimum. Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 3 days. Wait until post-earnings. Target $28.94 (+10.6%), stop $24.98 (−4.8%), A.R:R 2.1:1. Score 5.5/10, moderate confidence.
Take-profit target: $28.94 (+10.6% upside). Target $28.94 (+10.6%), stop $24.98 (−4.8%), A.R:R 2.1:1. Stop-loss: $24.98.
Koninklijke Philips N.V. NY Reg trades at a P/E of 22.8 (forward 12.9). TrendMatrix value score: 6.9/10. Verdict: Buy (Wait for Entry).
29 analysts cover PHG with a consensus score of 3.8/5. Average price target: $33.
What does Koninklijke Philips N.V. NY Reg do?Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and...
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.